Surgical Instrument Tracking Systems Market Share, Size, Trends, Industry Analysis Report, By Product (Hardware, Software, Services); By Technology; By Region; Segment Forecasts, 2021 - 2028
Description
The global surgical instrument tracking systems market size is expected to reach USD 817.43 million by 2034 according to a new study by Polaris Market Research. The report “Surgical Instrument Tracking Systems Market Share, Size, Trends, Industry Analysis Report, By Product (Hardware, Software, Services); By Technology; By Region; Segment Forecasts, 2025 - 2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The increased regulation for surgical instrument tracking systems in countries like the U.S. and China is the major factor that is driving the growth of the industry globally. The increased adoption owing to better patient practices in hospitals along with the emergence of new tracking system technologies is expected to further boost the growth of the industry.
Medical instrument tracing improves the sterile processing and distribution processes of the medical devices in hospitals that greatly contribute to patient safety. There is also an increased case of retained equipment after surgery and the mortality rate is 2% in the case of retained surgical objects and hence the adaptation of 2D barcodes and RFID to track devices in operation theatres will help to reduce any mishap during surgeries.
COVID-19 is expected to have a negative impact on the industry as most of the countries are following temporary lockdown and this has affected the transportation of medical devices. The temporary shutdown of medical device manufacturing sites in worst-affected countries and travel restrictions impacting shipments is expected to slow down the growth of the industry. The situation is expected to gradually improve in the few months after which the market is expected to witness upward growth.
Industry Participants such as Spatrack Medical Limited, Censis Technologies, Inc., Xerafy Singapore Pte Ltd., Getinge AB, Fingerprint Medical Limited, B. Braun Melsungen AG, Haldor Advanced Technologies, BD, Microsystems, INC, and Ternio Group LLC., are some of the key players operating in the global market.
Polaris Market Research has segmented the surgical instrument tracking systems market report on the basis of product, technology, end-users, and region:
Surgical Instrument Tracking Systems, Product Outlook (Revenue - USD Million, 2020 – 2034)
Hardware
Software
Services
Surgical Instrument Tracking Systems, Technology Outlook (Revenue - USD Million, 2020 – 2034)
Barcodes
Radio Frequency Identification (RFID)
Surgical Instrument Tracking Systems, End-Use Outlook (Revenue - USD Million, 2020 – 2034)
Hospitals
Others
Surgical Instrument Tracking Systems, Regional Outlook (Revenue - USD Million, 2020 – 2034)
North America
U.S.
Canada
Europe
Germany
UK
Italy
France
Spain
Netherlands
Austria
Asia Pacific
China
Japan
India
Indonesia
Malaysia
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Israel
Saudi Arabia
South Africa
UAE
The increased regulation for surgical instrument tracking systems in countries like the U.S. and China is the major factor that is driving the growth of the industry globally. The increased adoption owing to better patient practices in hospitals along with the emergence of new tracking system technologies is expected to further boost the growth of the industry.
Medical instrument tracing improves the sterile processing and distribution processes of the medical devices in hospitals that greatly contribute to patient safety. There is also an increased case of retained equipment after surgery and the mortality rate is 2% in the case of retained surgical objects and hence the adaptation of 2D barcodes and RFID to track devices in operation theatres will help to reduce any mishap during surgeries.
COVID-19 is expected to have a negative impact on the industry as most of the countries are following temporary lockdown and this has affected the transportation of medical devices. The temporary shutdown of medical device manufacturing sites in worst-affected countries and travel restrictions impacting shipments is expected to slow down the growth of the industry. The situation is expected to gradually improve in the few months after which the market is expected to witness upward growth.
Industry Participants such as Spatrack Medical Limited, Censis Technologies, Inc., Xerafy Singapore Pte Ltd., Getinge AB, Fingerprint Medical Limited, B. Braun Melsungen AG, Haldor Advanced Technologies, BD, Microsystems, INC, and Ternio Group LLC., are some of the key players operating in the global market.
Polaris Market Research has segmented the surgical instrument tracking systems market report on the basis of product, technology, end-users, and region:
Surgical Instrument Tracking Systems, Product Outlook (Revenue - USD Million, 2020 – 2034)
Hardware
Software
Services
Surgical Instrument Tracking Systems, Technology Outlook (Revenue - USD Million, 2020 – 2034)
Barcodes
Radio Frequency Identification (RFID)
Surgical Instrument Tracking Systems, End-Use Outlook (Revenue - USD Million, 2020 – 2034)
Hospitals
Others
Surgical Instrument Tracking Systems, Regional Outlook (Revenue - USD Million, 2020 – 2034)
North America
U.S.
Canada
Europe
Germany
UK
Italy
France
Spain
Netherlands
Austria
Asia Pacific
China
Japan
India
Indonesia
Malaysia
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Israel
Saudi Arabia
South Africa
UAE
Table of Contents
121 Pages
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. Japan Antibiotics Market Insights
- 4.1. Japan Antibiotics Market – Market Snapshot
- 4.2. Japan Antibiotics Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising Incidence of Bacterial Infections
- 4.2.1.2. Expansion of the Geriatric Population Susceptible to Infections
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Antibiotic Resistance and Regulatory Hurdles
- 4.2.3. Public opinion and privacy legal precedents
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Japan Antibiotics Market Trends
- 4.6. Value Chain Analysis
- 5. Japan Antibiotics Market, By Drug Class
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Japan Antibiotics Market, By Drug Class, 2020–2034 (USD Billion)
- 5.3. Cephalosporin
- 5.3.1. Japan Antibiotics Market, by Cephalosporin,2020–2034 (USD Billion)
- 5.4. Penicillin
- 5.4.1. Japan Antibiotics Market, by Penicillin,2020–2034 (USD Billion)
- 5.5. Fluoroquinolone
- 5.5.1. Japan Antibiotics Market, by Fluoroquinolone,2020–2034 (USD Billion)
- 5.6. Macrolides
- 5.6.1. Japan Antibiotics Market, by Macrolides,2020–2034 (USD Billion)
- 5.7. Carbapenems
- 5.7.1. Japan Antibiotics Market, by Carbapenems,2020–2034 (USD Billion)
- 5.8. Aminoglycosides
- 5.8.1. Japan Antibiotics Market, by Aminoglycosides,2020–2034 (USD Billion)
- 5.9. Sulfonamides
- 5.9.1. Japan Antibiotics Market, by Sulfonamides,2020–2034 (USD Billion)
- 5.10. 7-ACA
- 5.10.1. Japan Antibiotics Market, by 7-ACA,2020–2034 (USD Billion)
- 5.11. Others
- 5.11.1. Japan Antibiotics Market, by Others,2020–2034 (USD Billion)
- 6. Japan Antibiotics Market, By Type
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Japan Antibiotics Market, By Type, 2020–2034 (USD Billion)
- 6.3. Branded Antibiotics
- 6.3.1. Japan Antibiotics Market, by Branded Antibiotics,2020–2034 (USD Billion)
- 6.4. Generic Antibiotics
- 6.4.1. Japan Antibiotics Market, by Generic Antibiotics,2020–2034 (USD Billion)
- 7. Japan Antibiotics Market, By Action Mechanism
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Japan Antibiotics Market, By Action Mechanism, 2020–2034 (USD Billion)
- 7.3. Cell Wall Synthesis Inhibitors
- 7.3.1. Japan Antibiotics Market, by Cell Wall Synthesis Inhibitors,2020–2034 (USD Billion)
- 7.4. Protein Synthesis Inhibitors
- 7.4.1. Japan Antibiotics Market, by Protein Synthesis Inhibitors,2020–2034 (USD Billion)
- 7.5. DNA Synthesis Inhibitors
- 7.5.1. Japan Antibiotics Market, by DNA Synthesis Inhibitors,2020–2034 (USD Billion)
- 7.6. RNA Synthesis Inhibitors
- 7.6.1. Japan Antibiotics Market, by RNA Synthesis Inhibitors,2020–2034 (USD Billion)
- 7.7. Mycolic Acid Inhibitors
- 7.7.1. Japan Antibiotics Market, by Mycolic Acid Inhibitors,2020–2034 (USD Billion)
- 8. Competitive Landscape
- 8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
- 8.2. Partnerships/Collaborations/Agreements/Exhibitions
- 9. Company Profiles
- 9.1. Astellas Pharma Inc.
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
- 9.2. DAIICHI SANKYO COMPANY, LIMITED
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
- 9.3. GSK (GlaxoSmithKline K.K.)
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
- 9.4. KYORIN Pharmaceutical Co., Ltd.
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
- 9.5. Meiji Seika Pharma Co., Ltd.
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
- 9.6. Merck & Co., Inc.
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
- 9.7. Pfizer Inc.
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
- 9.8. Sawai Pharmaceutical Co., Ltd.
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
- 9.9. Shionogi & Co., Ltd.
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
- 9.10. Taisho Pharmaceutical Co., Ltd.
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.